virus
one
major
caus
acut
chronic
infecti
diseas
thu
major
contributor
global
burden
diseas
sever
studi
shown
virus
evolv
hijack
basic
cellular
pathway
evad
innat
immun
respons
modul
key
host
factor
signal
pathway
collect
view
multipl
studi
could
advanc
understand
virushost
interact
provid
new
therapeut
perspect
treatment
viral
diseas
perform
integr
metaanalysi
elucid
differ
hostviru
interactom
network
bioinformat
analys
show
virus
small
genom
effici
achiev
maxim
effect
target
multifunct
highli
connect
host
protein
high
occurr
disord
region
also
identifi
core
cellular
process
subnetwork
target
virus
integr
function
rna
interfer
rnai
dataset
show
larg
proport
target
requir
viral
replic
furthermor
perform
interactomeinform
drug
repurpos
screen
identifi
novel
activ
broadspectrum
antivir
agent
hepat
c
viru
human
metapneumoviru
altogeth
orthogon
dataset
could
serv
platform
hypothesi
gener
followup
studi
broaden
understand
viral
evas
landscap
virus
one
major
caus
acut
chronic
infecti
diseas
thu
major
contributor
global
burden
diseas
sever
studi
shown
virus
evolv
hijack
basic
cellular
pathway
evad
innat
immun
respons
modul
key
host
factor
signal
pathway
collect
view
multipl
studi
could
advanc
understand
virushost
interact
provid
new
therapeut
perspect
treatment
viral
diseas
perform
integr
metaanalysi
elucid
differ
hostviru
interactom
network
bioinformat
analys
show
virus
small
genom
effici
achiev
maxim
effect
target
multifunct
highli
connect
host
protein
high
occurr
disord
region
also
identifi
core
cellular
process
subnetwork
target
virus
integr
function
rna
interfer
rnai
dataset
show
larg
proport
target
requir
viral
replic
furthermor
perform
interactomeinform
drug
repurpos
screen
identifi
novel
activ
broadspectrum
antivir
agent
hepat
c
viru
human
metapneumoviru
altogeth
orthogon
dataset
could
serv
platform
hypothesi
gener
followup
studi
broaden
understand
viral
evas
landscap
virus
continu
major
contributor
global
burden
diseas
acut
chronic
infect
caus
substanti
econom
impact
addit
increas
mortal
morbid
despit
tremend
improv
understand
antivir
immun
respons
avail
therapeut
exist
emerg
viral
diseas
evergrow
problem
particularli
develop
countri
develop
antivir
resist
hepat
c
viru
hcv
influenza
viru
iav
herp
simplex
viru
hsv
human
cytomegaloviru
hcmv
human
immunodefici
viru
hiv
virus
major
concern
one
main
reason
increas
resist
accumul
mutat
viral
genom
caus
multipl
factor
includ
polymeras
infidel
therefor
world
health
organ
unit
nation
urg
better
control
viral
diseas
led
turn
focu
host
therapeut
intervent
target
host
factor
proven
use
restrict
viral
infect
small
molecul
inhibitor
maraviroc
monoclon
antibodi
ibalizumab
exampl
success
use
hostdirect
therapi
combat
hiv
clinic
virus
evolv
evad
host
antivir
respons
variou
stage
start
viral
sens
antivir
proinflammatori
respons
multipl
studi
attempt
understand
global
principl
viral
evas
employ
variou
virus
includ
dengu
viru
denv
ebola
viru
ebov
iav
hiv
global
systemslevel
approach
includ
function
rnai
screen
interactom
map
technolog
affinitypurif
mass
spectrometri
apm
quantit
proteom
screen
provid
unparallel
detail
insight
dynam
host
proteom
immun
cell
hostviru
interactom
also
identifi
import
host
depend
factor
variou
virus
metaanalys
highdimension
dataset
crucial
identifi
novel
host
factor
drug
target
iav
infect
moreov
factor
repres
drug
target
multipl
virus
hypothes
combin
metaanalysi
hostviru
proteinprotein
interact
multipl
virus
function
rnai
screen
would
provid
novel
insight
develop
broadspectrum
antivir
strategi
assembl
hostviru
proteinprotein
interactom
hostviru
interact
hereaft
refer
hvppi
cover
viral
protein
differ
virus
host
protein
perform
extens
bioinformat
network
analysi
integr
dataset
genomewid
druggablegenom
rnai
screen
data
publish
studi
result
assembl
critic
node
viral
evas
identif
core
cellular
process
druggabl
node
verifi
drug
repurpos
screen
use
broadspectrum
antivir
hostviru
proteinprotein
interact
download
publish
studi
perform
geneset
enrich
analysi
use
david
bioinformat
resourc
version
enrich
analysi
pvalu
cutoff
use
signific
protein
disord
analysi
perform
use
softwar
use
offlin
version
protein
sequenc
download
uniprot
statist
analysi
disord
region
distribut
perform
kolmogorovsmirnov
test
r
statist
environ
annot
human
protein
map
uniprot
id
ensembl
use
index
subcellular
local
interact
partner
singl
viral
protein
calcul
viral
protein
five
host
target
local
host
target
map
use
compart
filter
minimum
evid
score
knowledg
channel
exclud
nonexperiment
base
local
predict
evid
protein
subsequ
divid
absolut
number
hosttarget
per
viral
protein
multipl
sequenc
align
perform
use
clustal
x
version
genomewid
rnai
screen
data
hcv
genomernai
databas
well
druggabl
rnai
screen
data
vacv
integr
exist
network
zscore
druggen
interact
data
download
dgidb
drugbank
identifi
map
uniprot
id
compar
hvppi
hmpv
screen
approxim
human
retin
pigment
epitheli
rpe
cell
seed
per
well
plate
human
nonmalign
rpe
cell
line
repres
excel
model
system
studi
replic
mani
virus
includ
respiratori
cell
grown
h
medium
supplement
fb
nahco
streptomicin
iuml
penicillin
medium
replac
viru
growth
medium
vgm
contain
bovin
serum
albumin
bsa
mm
lglutamin
nahco
chloromethyl
ketonetrypsin
hcv
screenassoci
cell
cultur
condit
describ
kim
et
al
compound
ad
cell
dilut
seven
differ
concentr
start
compound
ad
control
well
cell
mockor
virusinfect
multipl
infect
moi
one
h
infect
medium
remov
cell
monitor
cell
viabil
celltiterglo
reagent
ad
per
well
assay
quantifi
atp
indic
metabol
activ
live
cell
luminesc
measur
plate
reader
determin
compound
efficaci
hmpv
gfp
express
measur
halfmaxim
cytotox
concentr
cc
halfmaxim
effect
concentr
ec
compound
calcul
nonlinear
regress
analysi
variabl
slope
use
graphpad
prism
softwar
version
rel
effect
drug
quantifi
select
index
si
cc
ec
cytotox
antivir
activ
compound
gfpexpress
hcv
cell
determin
previous
describ
provid
new
critic
insight
viral
evas
mechan
perform
comprehens
metaanalysi
hostviru
interact
landscap
assembl
hostviru
proteinprotein
interact
data
hvppi
publish
studi
figur
dataset
compris
proteinprotein
interact
two
differ
type
experiment
methodsaffin
purif
mass
spectrometri
apm
yeast
twohybrid
screen
altogeth
combin
dataset
includ
viral
protein
host
protein
proteinprotein
interact
figur
figur
mani
interactom
network
includ
yeast
human
scalefre
network
larg
portion
node
eg
protein
network
interact
node
larg
number
interact
latter
often
refer
hub
crucial
keep
network
intact
perform
network
topolog
analysi
infer
properti
host
protein
target
viral
protein
context
human
protein
interactom
consid
two
import
parametersrel
between
central
reflect
amount
inform
pass
protein
human
interactom
degre
number
bind
partner
human
interactom
host
protein
target
viru
target
virus
show
higher
between
central
degre
compar
averag
protein
human
interactom
figur
show
virus
target
hub
protein
serv
key
commun
node
evolv
best
way
disrupt
scalefre
human
interactom
topolog
properti
therebi
show
virus
small
genom
achiev
maxim
effect
rewir
human
interactom
benefit
viral
surviv
replic
analysi
agreement
sever
previou
studi
highlight
properti
propos
could
gener
principl
virus
protein
typic
fold
stabl
threedimension
structur
mediat
specif
function
addit
substructur
protein
term
intrins
disord
region
idr
lack
stabl
structur
normal
physiolog
condit
idr
requir
multipl
cellular
function
even
though
lack
defin
structur
mani
studi
highlight
presenc
idr
viral
protein
human
papilloma
viru
crucial
hijack
cellular
machineri
analyz
host
protein
hvppi
presenc
idr
use
predict
softwar
iupr
estim
human
proteom
short
linear
bind
motif
idr
protein
idr
often
signal
hub
might
form
dynam
complex
protein
specif
motif
base
interact
found
statist
signific
enrich
pvalu
idr
host
protein
target
virus
figur
figur
identifi
subnetwork
hvppi
contain
top
host
target
high
disord
score
figur
top
five
protein
larg
idr
includ
antigen
serinearginin
repetit
matrix
protein
myristoyl
alaninerich
ckinas
substrat
marck
bag
famili
molecular
chaperon
regul
mitochondri
antiviralsign
protein
mav
figur
marker
exhaust
cell
replic
hcv
cell
shown
decreas
cell
prolifer
inhibit
express
signal
serineargininerich
protein
involv
rna
splice
differenti
phosphoryl
infect
cell
absenc
lead
increas
gene
express
sinc
regul
splice
hvppi
target
multipl
viral
protein
includ
tat
protein
tat
protein
import
role
stimul
transcript
long
termin
repeat
ltr
addit
protein
influenza
b
viru
also
report
interact
protein
marck
famili
involv
rang
cellular
process
includ
cell
adhes
migrat
marck
neg
regul
lipopolysaccharid
lp
induc
tolllik
receptor
signal
mous
macrophag
mav
adaptor
protein
rigi
signal
pathway
involv
sens
rna
ablass
et
al
report
doublestrand
dna
serv
templat
rna
polymeras
ii
transcrib
triphosph
contain
doublestrand
rna
activ
rigi
signal
pathway
hvppi
mav
target
sever
protein
dsdna
virus
ebv
hpv
altogeth
analysi
show
idrhigh
part
human
proteom
essenti
part
viral
evas
strategi
select
target
highlight
could
show
novel
insight
viral
evas
mechan
howev
flexibl
protein
structur
disord
protein
also
make
also
difficult
target
drug
assess
signal
pathway
cellular
process
within
hvppi
identifi
highli
connect
subnetwork
within
hvppi
network
construct
hosthost
interact
network
base
host
target
hvppi
identifi
number
highli
connect
subnetworksclust
figur
perform
geneset
enrich
analysi
significantli
enrich
biolog
process
found
one
enrich
process
subnetwork
includ
core
cellular
process
proteasom
spliceosom
protein
translat
proteinrna
transport
cell
cycl
next
list
virus
target
one
process
found
almost
core
pathway
process
target
virus
part
hvppi
figur
analysi
highlight
core
compon
cellular
process
subnetwork
target
part
viral
evas
strategi
thu
could
broadspectrum
antivir
hotspot
therapeut
point
view
given
viral
protein
interact
larg
number
host
protein
analyz
subcellular
locat
host
protein
perform
geneset
enrich
analysi
subcellular
local
inform
provid
uniprot
databas
bin
local
compart
estim
percent
host
protein
given
compart
compar
total
number
host
protein
target
given
figur
cluster
hvppi
involv
core
cellular
process
network
view
cluster
highlyconnect
subnetwork
associ
cellular
process
cluster
mark
uniqu
color
viru
found
viral
target
distribut
across
multipl
subcellular
compart
cytoplasm
common
figur
hvppi
includ
two
differ
strain
udorn
subcellular
local
analysi
show
strain
enrich
nuclear
protein
nonstructur
protein
strain
highest
number
nuclear
target
target
differ
figur
udorn
enrich
larg
number
histon
compar
larg
number
heterogen
nuclear
ribonucleoprotein
hnrnp
known
restrict
factor
mani
virus
corrobor
observ
protein
short
linear
histon
mimicri
motif
suppress
host
antivir
respons
analysi
found
udorn
histon
mimicri
motif
arsk
figur
similarli
protein
interact
often
host
protein
locat
endoplasm
reticulum
er
found
common
specif
subset
er
protein
target
protein
figur
protein
er
target
enrich
phospholipid
biosynthesi
well
gpi
anchor
relat
protein
phosphatidylinositol
glycan
anchor
biosynthesi
class
stu
pig
pigt
pigu
glycosylphosphatidylinositol
anchor
attach
phosphatidylserin
synthas
protein
er
target
enrich
erassoci
ubiquitindepend
protein
catabol
involv
host
protein
er
degrad
enhanc
alphamannosidaselik
protein
er
lipid
raft
associ
er
target
common
protein
enrich
unfold
protein
respons
nlink
glycosyl
protein
fold
involv
host
protein
srp
receptor
alphabeta
subunit
srprasrprb
catalyt
subunit
oligosaccharyltransferas
complex
two
independ
screen
studi
identifi
multipl
er
associ
compon
includ
host
factor
denv
zika
viru
zikv
japanes
enceph
viru
jev
noncanon
function
requir
denv
replic
protein
denv
interact
protein
orthogon
approach
lead
identif
critic
host
factor
similar
function
er
compon
use
well
thu
target
noncanon
function
could
broad
antivir
strategi
overal
enrich
analysi
clearli
show
common
specif
subcellular
target
viral
protein
detail
interrog
target
give
vital
clue
viral
evas
mechan
rnai
screen
power
highthroughput
method
identifi
variou
cellular
function
includ
identif
host
restrict
factor
virus
order
explor
function
relev
host
target
hvppi
integr
five
publish
rnai
screen
perform
genomewid
druggablegenomewid
rnai
screen
identifi
host
factor
hcv
vacv
found
host
target
hvppi
spread
across
spectrum
gene
provir
well
antivir
phenotyp
figur
thu
show
target
host
protein
viru
could
lead
direct
favor
viru
investig
top
provir
gene
also
target
viral
protein
seen
hvppi
identifi
host
protein
figur
significantli
enrich
coatom
protein
complex
copi
protein
translationtransport
proteasom
figur
substanti
find
earlier
section
core
cellular
process
target
virus
network
analysi
top
hit
show
high
level
connect
crosstalkfor
exampl
translat
proteasom
machineri
figur
vesicl
carrier
involv
transport
membran
protein
copi
system
one
three
vesicular
carrier
system
involv
earli
secretori
pathway
moreov
point
strong
similar
vesicular
transport
viral
transport
viral
entri
bud
process
thu
make
copi
system
import
viral
life
cycl
addit
find
present
studi
sirnabas
silenc
copi
lead
decreas
entri
subsequ
gene
express
iav
vsv
lcmv
disrupt
copi
complex
inhibit
product
infecti
progeni
viru
copi
coatom
inactiv
result
direct
decreas
vsv
attach
uptak
membran
fusion
rnp
releas
howev
direct
mechan
remain
unclear
altogeth
top
hit
includ
copi
system
could
serv
target
develop
therapeut
antivir
intervent
strategi
broad
group
virus
analys
point
viral
evas
mechan
observ
one
viru
could
also
relev
virus
test
obtain
known
druggen
interact
dgidb
select
investigationalexperimentalapprov
antivir
compound
dgidb
annot
target
part
hvppi
ad
agent
control
tabl
figur
test
broadspectrumantivir
gfpexpress
human
metapneumoviru
hmpv
strain
seven
differ
concentr
compound
ad
hmpv
mockinfect
cell
hmpvinduc
gfp
express
cell
viabil
measur
h
determin
compound
effici
toxic
initi
screen
identifi
five
compound
lower
gfpexpress
without
detect
cytotox
si
repeat
experi
compound
experi
reveal
novel
activ
azacytidin
lopinavir
nitazoxanid
itraconazol
oritavancin
hmpv
figur
tabl
tabl
similarli
examin
toxic
antivir
activ
broadspectrumantivir
gfpexpress
hcv
cell
use
previous
describ
procedur
test
identifi
azithromycin
cidofovir
oritavancin
dibucain
gefitinib
minocyclin
pirlindol
mesyl
novel
antihcv
agent
si
figur
tabl
tabl
summari
metaanalysi
approach
hvppi
could
provid
novel
faster
approach
repurpos
exist
drug
antivir
agent
use
integr
analysi
orthogon
dataset
studi
provid
comprehens
view
viral
evas
mechan
particular
analysi
hvppi
network
reveal
virus
evolv
target
protein
central
strong
control
human
interactom
host
protein
target
virus
contain
high
proport
intrins
disord
region
identifi
core
cellular
process
associ
protein
target
virus
detail
compar
analysi
subcellular
local
host
protein
show
common
specif
viral
protein
differ
strain
viru
virus
integr
hvppi
function
rnai
screen
show
hvppi
host
factor
one
viru
hvppi
databas
drug
repurpos
screen
identifi
novel
activ
variou
broadspectrum
antivir
hmpv
hcv
uniqu
dataset
use
detail
interrog
mechan
behind
viral
evas
could
serv
start
point
identifi
novel
host
target
gener
hypothesi
context
viral
evas
develop
panvir
therapeut
intervent
strategi
method
describ
also
provid
uniqu
way
dissect
orthogon
dataset
variou
analys
studi
highlight
exist
panvir
evas
point
could
util
develop
hostdirect
antivir
therapi
also
intrigu
see
common
specif
level
sub
cellular
local
viral
target
analys
underlin
salient
featur
context
iav
hpv
denv
hcv
detail
analysi
context
along
protein
sequenc
featur
short
linear
motif
slim
would
provid
novel
insight
well
deeper
understand
small
sequenc
featur
involv
hijack
host
machineri
integr
data
known
druggen
interact
provid
clear
estim
druggabl
proport
hvppi
metaanalysi
approach
hvppi
could
provid
novel
avenu
repurpos
exist
drug
antivir
target
strategi
metaanalysi
approach
hvppi
could
provid
novel
avenu
repurpos
exist
drug
antivir
target
strategi
prove
concept
test
bsa
hmpv
hcv
sindbi
viru
sinv
cytomegaloviru
cmv
hepat
b
viru
hbv
importantli
bsa
dgidb
annot
target
part
hvppi
wherea
use
control
safeinman
drug
alreadi
use
investig
agent
experiment
drug
differ
viru
infect
tabl
demonstr
novel
antivir
effect
azacytidin
itraconazol
lopinavir
nitazoxanid
oritavancin
hmpv
well
cidofovir
dibucain
azithromycin
gefitinib
minocyclin
oritavancin
pirlindol
hcv
azithromycin
fdaapprov
antibiot
macrolid
famili
also
investig
agent
rsv
experiment
agent
ebov
hrva
zikv
rsv
cidofovir
fdaapprov
anticmv
drug
also
investig
agent
adv
bkv
hpv
experiment
drug
dibucain
fdaapprov
amid
local
anesthet
addit
experiment
antiheva
hevb
hevd
ebov
agent
gefitinib
fda
approv
anticanc
drug
also
antivir
activ
bkv
cmv
vacv
minocyclin
broadspectrum
antibiot
experiment
antidenv
wnv
agent
oritavancin
semisynthet
glycopeptid
antibiot
use
treatment
gramposit
bacteri
skin
infect
also
inhibit
ebov
merscov
sarscov
infect
pirlindol
antidepress
also
experiment
antiheva
hevb
hevd
agent
azacitidin
chemic
analog
cytidin
use
treatment
myelodysplast
syndrom
also
experiment
antiadv
measur
repeat
three
time
p
fluav
rvfv
agent
itraconazol
antifung
medic
also
use
experiment
antihevb
hrvb
hrva
safv
agent
nitazoxanid
broadspectrum
antiparasit
drug
also
investig
agent
fluav
hcv
experiment
antichikv
rsv
hbv
vacv
rv
jev
merscov
nov
ruv
zikv
agent
lopinavir
fdaapprov
antiretrovir
proteas
inhibitor
class
also
investig
antimerscov
experiment
antizikv
agent
tabl
addit
inhibit
viral
proteas
tabl
lopinavir
report
induc
host
rnasel
product
infect
noninfect
cell
rnasel
endoribonucleas
part
interferon
ifn
antivir
respons
critic
node
virushost
interact
although
antivir
mechan
action
compound
still
unknown
agent
could
inhibit
step
viral
infect
preced
report
protein
express
viral
rna
summari
result
indic
exist
bsa
could
repurpos
viral
infect
expand
spectrum
activ
bsa
could
test
virus
repurpos
safeinman
antivir
therapeut
could
save
resourc
time
need
develop
novel
drug
quickli
address
unmet
medic
need
safeti
profil
agent
human
avail
effect
treatment
broadspectrumantivir
may
shortli
becom
avail
pend
result
preclin
studi
clinic
trial
turn
mean
broadspectrumantivir
could
use
rapid
manag
new
emerg
drugresist
strain
well
firstlin
treatment
prophylaxi
acut
viru
infect
viral
coinfect
effect
toler
compound
could
expand
avail
therapeut
treatment
viral
diseas
improv
prepared
protect
gener
popul
viral
epidem
pandem
dataset
use
studi
access
state
materi
method
section
thank
christian
sinzger
group
egfpexpress
cmv
strain
thank
vironov
erasmu
mc
gfpexpress
hmpv
strain
supplementari
materi
articl
found
onlin
http
supplementarymateri
